Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 13/20 | 0.64 |
| ▸ | CASP3 | P42574 | 9/20 | 0.64 |
| ▸ | CASP9 | P55211 | 6/20 | 0.64 |
| ▸ | CASP7 | P55210 | 6/20 | 0.64 |
| ▸ | CASP10 | Q92851 | 3/20 | 0.52 |
| ▸ | MME | P08473 | 2/20 | 0.51 |
| ▸ | ECE1 | P42892 | 2/20 | 0.51 |
| ▸ | CASP4 | P49662 | 3/20 | 0.51 |
| ▸ | CASP8 | Q14790 | 2/20 | 0.50 |
| ▸ | CASP5 | P51878 | 1/20 | 0.50 |
| ▸ | CASP6 | P55212 | 1/20 | 0.50 |
| ▸ | BACE1 | P56817 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Naphthalene SCHEMBL8414904 | 0.88 | CASP1 (0.64) | CASP1CASP3CASP9CASP7CASP4 | |
| SCHEMBL7464267 | 0.88 | CASP3 (0.49) | CASP1CASP3CASP9CASP7CASP8 | |
| SCHEMBL7423249 | 0.88 | CASP1 (0.54) | CASP1CASP3CASP7MMEECE1 | |
| SCHEMBL7423065 | 0.87 | BACE1 (0.57) | CASP1CASP3CASP9CASP7BACE1 | |
| SCHEMBL30002726 | 0.87 | CASP3 (0.69) | CASP1CASP3CASP9CASP7CASP10 | |
| SCHEMBL29362585 | 0.86 | CASP3 (0.76) | CASP1CASP3CASP9CASP7CASP10 | |
| SCHEMBL17326941 | 0.85 | CASP3 (0.72) | CASP1CASP3CASP9CASP7CASP10 | |
| SCHEMBL20239336 | 0.85 | CASP3 (0.71) | CASP1CASP3CASP9CASP7CASP10 | |
| SCHEMBL29732392 | 0.85 | CASP3 (0.71) | CASP1CASP3CASP9CASP7CASP10 | |
| SCHEMBL7418130 | 0.84 | CASP1 (0.72) | CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0932598-A1 | ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME | WARNER-LAMBERT COMPANY (US) | 1999-08-04 | — | — | EP | claimed |
| WO-1998016502-A1 | ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME | WARNER-LAMBERT COMPANY (US) | 1998-04-23 | — | — | WO | claimed |
| WO-2001019373-A2 | METHODS AND COMPOSITIONS FOR MODULATING RESPONSIVENESS TO CORTICOSTEROIDS | BASF AKTIENGESELLSCHAFT (DE) | 2001-03-22 | — | — | WO | disclosed |
| EP-0998300-A1 | METHODS AND COMPOSITIONS FOR MODULATING RESPONSIVENESS TO CORTICOSTEROIDS | BASF AKTIENGESELLSCHAFT (DE) | 2000-05-10 | — | — | EP | disclosed |
| EP-0932598-A1 | ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME | WARNER-LAMBERT COMPANY (US) | 1999-08-04 | — | — | EP | disclosed |
| WO-1998041232-A2 | COMPOSITIONS FOR MODULATING RESPONSIVENESS TO CORTICOSTEROIDS | BASF AKTIENGESELLSCHAFT (DE) | 1998-09-24 | — | — | WO | disclosed |
| WO-1998016502-A1 | ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME | WARNER-LAMBERT COMPANY (US) | 1998-04-23 | — | — | WO | disclosed |